Sector comparison

  Boston Scient...Edwards Lifes...Becton, Dicki...IDEXX Laborat...Nasdaq 100
Overview  
ISIN  US1011371077US28176E1082US0758871091US45168D1046US6311011026
Market Capitalization
131.78 bill. EUR37.44 bill. EUR59.63 bill. EUR31.04 bill. EUR-
Shares Outstanding
1.48 bill.587.9 mill.287.14 mill.81.33 mill.-
Dividend per Share*
- - 3.80 USD- -
Dividend Yield
--1.68%--
P/E Ratio
77.119.9338.4338.56-
P/E Ratio (with EPS Diluted)*
71.4610.6241.1438.75-
Free Float
-83.04%77.40%57.24%-
Performance  
Exchange  NYSENYSENYSENASDAQIndices Nasdaq
1 Week
+3.22%+1.11%-0.65%-4.85%+1.41%
1 Month
-8.43%-9.06%+0.52%-6.58%-10.90%
3 Months
+7.44%-6.52%+0.15%-2.76%-10.44%
YTD
+8.78%-6.40%-0.39%+0.45%-6.22%
1 Year
+46.70%-24.94%-4.53%-21.61%+10.65%
3 Years
+119.77%-38.43%-11.63%-21.21%+39.57%
5 Years
+237.48%+17.84%-6.73%+92.38%+163.64%
Fundamentals  2024202420242024-
Accounting Standard  US GAAPUS GAAPUS GAAPUS GAAP-
Revenues (in mill.)
16,747 USD5,439.5000 USD20,178 USD3,897.5040 USD-
Revenues Growth Rate
17.61%-9.41%4.16%6.46%-
EBITDA (in mill.)
- - - - -
Operating Result (in mill.)
2,603 USD1,378.7000 USD2,397 USD1,128.3370 USD-
Income Before Taxes (in mill.)
2,282 USD1,548.1000 USD2,005 USD1,109.8310 USD-
Net Income (in mill.)
1,853 USD4,174.6000 USD1,705 USD887.8670 USD-
Net Income Growth Rate
18.03%197.68%19.73%5.07%-
Earnings per Share
1.26 USD6.98 USD5.88 USD10.77 USD- USD
Total Equity (in mill.)
22,003 USD10,062.9000 USD25,890 USD1,595.3130 USD-
Equity Ratio
55.85%77.08%45.19%48.44%-
Return on Equity
8.42%41.49%6.59%55.65%-
Book Value per Share
14.91 USD17.12 USD89.55 USD19.62 USD-
Total Assets (in mill.)
39,395 USD13,055.3000 USD57,286 USD3,293.4430 USD-
Return on Assets
4.70%31.98%2.98%26.96%-
Operating Cash Flow (in mill.)
3,435 USD542.3000 USD3,844 USD929.0010 USD-

 * Latest financial year